P

Palatin Technologies
D

PTN

1.12000
USD
0.17
(17.89%)
Market Closed
Volume
8,223
EPS
-2
Div Yield
-
P/E
-1
Market Cap
21,893,947
Related Instruments
    A
    AKBA
    -0.07500
    (-4.02%)
    1.79000 USD
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    C
    CYCN
    0.79000
    (45.66%)
    2.52000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VBIV
    0
    (0%)
    0.000000 USD
    More
News

Title: Palatin Technologies

Sector: Healthcare
Industry: Biotechnology
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.